2021-07-22 11:30:00 -04:00
|
|
|
% \documentclass[twocolumn]{article}
|
|
|
|
\documentclass{report}
|
|
|
|
\usepackage[top=1in,left=1.5in,right=1in,bottom=1in]{geometry}
|
2021-07-09 12:39:33 -04:00
|
|
|
\usepackage{siunitx}
|
|
|
|
\usepackage[acronym]{glossaries}
|
|
|
|
\usepackage[T1]{fontenc}
|
|
|
|
\usepackage{enumitem}
|
|
|
|
\usepackage{titlesec}
|
|
|
|
\usepackage{titlecaps}
|
|
|
|
\usepackage{upgreek}
|
|
|
|
\usepackage{graphicx}
|
|
|
|
\usepackage{subcaption}
|
|
|
|
\usepackage{nth}
|
|
|
|
\usepackage[capitalize]{cleveref}
|
|
|
|
\usepackage[version=4]{mhchem}
|
|
|
|
\usepackage{pgfgantt}
|
2021-07-09 13:13:57 -04:00
|
|
|
\usepackage{setspace}
|
|
|
|
|
|
|
|
\doublespacing
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\titleformat{\chapter}[block]{\filcenter\bfseries\large}
|
|
|
|
{\MakeUppercase{\chaptertitlename} \thechapter: }{0pt}{\uppercase}
|
|
|
|
% \titleformat{\chapter}[block]{\filcenter\bfseries\large}{}{0pt}{\uppercase}
|
|
|
|
\titleformat{\section}[block]{\bfseries\large}{}{0pt}{\titlecap}
|
|
|
|
\titleformat{\subsection}[block]{\itshape\large}{}{0pt}{\titlecap}
|
|
|
|
\titleformat{\subsubsection}[runin]{\bfseries\itshape}{}{0pt}{\titlecap}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
\setlist[description]{font=$\bullet$~\textbf\normalfont}
|
|
|
|
|
|
|
|
\sisetup{per-mode=symbol,list-units=single}
|
|
|
|
\DeclareSIUnit\activityunit{U}
|
|
|
|
\DeclareSIUnit\carrier{carriers}
|
|
|
|
\DeclareSIUnit\cell{cells}
|
|
|
|
\DeclareSIUnit\ab{mAbs}
|
|
|
|
\DeclareSIUnit\molar{M}
|
|
|
|
\DeclareSIUnit\gforce{\times{} g}
|
|
|
|
|
|
|
|
% add acronyms here
|
|
|
|
\renewcommand{\glossarysection}[2][]{} % remove glossary title
|
|
|
|
\makeglossaries
|
|
|
|
\newacronym{act}{ACT}{adoptive cell therapies}
|
2021-07-09 13:13:57 -04:00
|
|
|
\newacronym{car}{CAR}{chimeric antigen receptor}
|
|
|
|
\newacronym[longplural={monoclonal antibodies}]{mab}{mAb}{monoclonal antibody}
|
|
|
|
\newacronym{ecm}{ECM}{extracellular matrix}
|
|
|
|
\newacronym{cqa}{CQA}{critical quality attribute}
|
|
|
|
\newacronym{cpp}{CPP}{critical process parameter}
|
|
|
|
\newacronym{dms}{DMS}{degradable microscaffold}
|
|
|
|
\newacronym{doe}{DOE}{design of experiments}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
\begin{document}
|
|
|
|
|
|
|
|
\begin{titlepage}
|
2021-07-09 13:13:57 -04:00
|
|
|
\begin{singlespace}
|
2021-07-09 12:39:33 -04:00
|
|
|
\begin{center}
|
2021-07-22 11:30:00 -04:00
|
|
|
\Large{
|
|
|
|
\textbf{Optimizing T Cell Manufacturing and Quality Using
|
2021-07-09 12:39:33 -04:00
|
|
|
Functionalized Degradable Microscaffolds}
|
|
|
|
|
|
|
|
\vfill
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
A Dissertation \\
|
|
|
|
Presented to \\
|
|
|
|
The Academic Faculty \\
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
\vspace{1.5em}
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
by
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
\vspace{1.5em}
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
Nathan John Dwarshuis, B.S. \\
|
|
|
|
|
|
|
|
\vfill
|
|
|
|
|
|
|
|
In Partial Fulfillment \\
|
|
|
|
of the Requirements for the Degree \\
|
|
|
|
Doctor of Philosophy in Biomedical Engineering in the \\
|
|
|
|
Wallace H. Coulter Department of Biomedical Engineering
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
\vfill
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
Georgia Institute of Technology and Emory University \\
|
|
|
|
August 2021
|
|
|
|
|
|
|
|
\vfill
|
|
|
|
|
|
|
|
COPYRIGHT \copyright{} BY NATHAN J. DWARSHUIS
|
|
|
|
}
|
2021-07-09 12:39:33 -04:00
|
|
|
\end{center}
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \large{
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \noindent
|
|
|
|
% Committee Members
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \vspace{1.5em}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \noindent
|
|
|
|
% Dr. Krishnendu Roy (Advisor) \\
|
|
|
|
% Wallace H. Coulter Department of Biomedical Engineering, Georgia
|
|
|
|
% Institute of Technology and Emory University
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \vspace{1.5em}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \noindent
|
|
|
|
% Dr. Madhav Dhodapkar \\
|
|
|
|
% Department of Hematology and Medical Oncology, Emory University
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \vspace{1.5em}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \noindent
|
|
|
|
% Dr. Melissa Kemp \\
|
|
|
|
% Wallace H. Coulter Department of Biomedical Engineering, Georgia
|
|
|
|
% Institute of Technology and Emory University
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \vspace{1.5em}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \noindent
|
|
|
|
% Dr. Wilbur Lam \\
|
|
|
|
% Wallace H. Coulter Department of Biomedical Engineering, Georgia
|
|
|
|
% Institute of Technology and Emory University
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \vspace{1.5em}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \noindent
|
|
|
|
% Dr. Sakis Mantalaris \\
|
|
|
|
% Wallace H. Coulter Department of Biomedical Engineering, Georgia
|
|
|
|
% Institute of Technology and Emory University }
|
2021-07-09 13:13:57 -04:00
|
|
|
\end{singlespace}
|
2021-07-09 12:39:33 -04:00
|
|
|
\end{titlepage}
|
|
|
|
|
|
|
|
\onecolumn \pagenumbering{roman}
|
|
|
|
\clearpage
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\chapter*{acknowledgements}
|
|
|
|
\addcontentsline{toc}{chapter}{acknowledgements}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
Thank you to Lex Fridman and Devin Townsend for being awesome and inspirational.
|
|
|
|
|
|
|
|
\clearpage
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\chapter*{summary}
|
|
|
|
\addcontentsline{toc}{chapter}{summary}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-09 13:13:57 -04:00
|
|
|
\Gls{act} using \gls{car} T cells have shown promise in treating cancer, but
|
|
|
|
manufacturing large numbers of high quality cells remains challenging. Currently
|
|
|
|
approved T cell expansion technologies involve anti-CD3 and CD28 \glspl{mab},
|
|
|
|
usually mounted on magnetic beads. This method fails to recapitulate many key
|
|
|
|
signals found \textit{in vivo} and is also heavily licensed by a few companies,
|
|
|
|
limiting its long-term usefulness to manufactures and clinicians. Furthermore,
|
|
|
|
we understand that highly potent T cells are generally less-differentiated
|
|
|
|
subtypes such as central memory and stem memory T cells. Despite this
|
|
|
|
understanding, little has been done to optimize T cell expansion for generating
|
|
|
|
these subtypes, including measurement and feedback control strategies that are
|
|
|
|
necessary for any modern manufacturing process.
|
|
|
|
|
|
|
|
The goal of this thesis was to develop a microcarrier-based \gls{dms} T cell
|
|
|
|
expansion system as well as determine biologically-meaningful \glspl{cqa} and
|
|
|
|
\glspl{cpp} that could be used to optimize for highly-potent T cells. In Aim 1,
|
|
|
|
we develop and characterized the \gls{dms} system, including quality control
|
|
|
|
steps. We also demonstrate the feasiblity of expanding highly-potent memory and
|
|
|
|
CD4+ T cells, and showing compatibility with existing \gls{car} transduction
|
|
|
|
methods. In aim 2, we use \gls{doe} methodology to optimize the \gls{dms}
|
|
|
|
platform, and develop a computational pipeline to identify and model the effect
|
|
|
|
of measurable \glspl{cqa} and \glspl{cpp} on the final product. In aim 3, we
|
|
|
|
demonstrate the effectiveness of the \gls{dms} platform \textit{in vivo}. This
|
|
|
|
thesis lays the groundwork for a novel T cell expansion method which can be used
|
|
|
|
in a clinical setting, and also provides a path toward optimizing for product
|
|
|
|
quality in an industrial setting.
|
|
|
|
|
2021-07-09 12:39:33 -04:00
|
|
|
\clearpage
|
|
|
|
|
|
|
|
\tableofcontents
|
|
|
|
|
|
|
|
\clearpage
|
|
|
|
|
|
|
|
\listoffigures
|
|
|
|
|
|
|
|
\clearpage
|
|
|
|
|
|
|
|
\listoftables
|
|
|
|
|
|
|
|
\clearpage
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
% \twocolumn
|
|
|
|
\chapter*{acronyms}
|
|
|
|
\addcontentsline{toc}{chapter}{acronyms}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
\printglossary[type=\acronymtype]
|
|
|
|
|
|
|
|
\clearpage
|
|
|
|
\pagenumbering{arabic}
|
|
|
|
|
|
|
|
\clearpage
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\chapter{introduction}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\section*{overview}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
Insert overview here
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\section*{hypothesis}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
Insert hypothesis here
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\section*{specific aims}
|
|
|
|
\subsection*{aim 1}
|
|
|
|
\subsection*{aim 2}
|
|
|
|
\subsection*{aim 3}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\section*{outline}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\subsection*{Aim 1}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
Aim 1
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\subsection*{Aim 2}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
Aim 2
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\subsection*{Aim 3}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
Aim 3
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\chapter{background and significance}
|
|
|
|
\subsection*{background}
|
|
|
|
\subsection*{current T cell manufacturing technologies}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
bla bla
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\section*{strategies to optimize cell manufacturing}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
bla bla
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\subsection*{strategies to characterize cell manufacturing}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
bla bla
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\section{Innovation}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\chapter{aim 1}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\section{introduction}
|
|
|
|
\section{methods}
|
|
|
|
\section{results}
|
|
|
|
\section{discussion}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\chapter{Aim 2}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\section{introduction}
|
|
|
|
\section{methods}
|
|
|
|
\section{results}
|
|
|
|
\section{discussion}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\chapter{Aim 3}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\section{introduction}
|
|
|
|
\section{methods}
|
|
|
|
\section{results}
|
|
|
|
\section{discussion}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\chapter{conclusions and future work}
|
|
|
|
\section{conclusions}
|
|
|
|
\section{future work}
|
2021-07-09 12:39:33 -04:00
|
|
|
|
|
|
|
\onecolumn
|
|
|
|
\clearpage
|
|
|
|
|
|
|
|
% TODO some people put appendices here....not sure if I need to
|
|
|
|
|
2021-07-22 11:30:00 -04:00
|
|
|
\chapter{References}
|
2021-07-09 12:39:33 -04:00
|
|
|
\renewcommand{\section}[2]{} % noop the original bib section header
|
|
|
|
|
|
|
|
\bibliography{../proposal}
|
|
|
|
|
|
|
|
\bibliographystyle{naturemag}
|
|
|
|
|
|
|
|
\end{document}
|